These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32765514)

  • 1. Editorial: ADAM10 in Cancer Immunology and Autoimmunity: More Than a Simple Biochemical Scissor.
    Rossello A; Steinle A; Poggi A; Zocchi MR
    Front Immunol; 2020; 11():1483. PubMed ID: 32765514
    [No Abstract]   [Full Text] [Related]  

  • 2. IDO1 can impair NK cells function against non-small cell lung cancer by downregulation of NKG2D Ligand via ADAM10.
    Fang X; Guo L; Xing Z; Shi L; Liang H; Li A; Kuang C; Tao B; Yang Q
    Pharmacol Res; 2022 Mar; 177():106132. PubMed ID: 35183714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKG2D Ligand Shedding in Response to Stress: Role of ADAM10.
    Zingoni A; Vulpis E; Loconte L; Santoni A
    Front Immunol; 2020; 11():447. PubMed ID: 32269567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma.
    Hansen HP; Paes Leme AF; Hallek M
    Front Immunol; 2020; 11():398. PubMed ID: 32296414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas.
    Zocchi MR; Catellani S; Canevali P; Tavella S; Garuti A; Villaggio B; Zunino A; Gobbi M; Fraternali-Orcioni G; Kunkl A; Ravetti JL; Boero S; Musso A; Poggi A
    Blood; 2012 Feb; 119(6):1479-89. PubMed ID: 22167753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro.
    Hansen HP; Trad A; Dams M; Zigrino P; Moss M; Tator M; Schön G; Grenzi PC; Bachurski D; Aquino B; Dürkop H; Reiners KS; von Bergwelt-Baildon M; Hallek M; Grötzinger J; Engert A; Paes Leme AF; Pogge von Strandmann E
    Oncotarget; 2016 May; 7(21):30523-35. PubMed ID: 27105521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Immune Responses by Platelet-Derived ADAM10.
    Maurer S; Kopp HG; Salih HR; Kropp KN
    Front Immunol; 2020; 11():44. PubMed ID: 32117229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arming cytotoxic lymphocytes for cancer immunotherapy by means of the NKG2D/NKG2D-ligand system.
    Lazarova M; Wels WS; Steinle A
    Expert Opin Biol Ther; 2020 Dec; 20(12):1491-1501. PubMed ID: 32726145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
    Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
    Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NKG2D axis: an emerging target in cancer immunotherapy.
    Lazarova M; Steinle A
    Expert Opin Ther Targets; 2019 Apr; 23(4):281-294. PubMed ID: 30732494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ADAM10 in Cancer and Autoimmunity.
    Smith TM; Tharakan A; Martin RK
    Front Immunol; 2020; 11():499. PubMed ID: 32265938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.
    Camodeca C; Nuti E; Tepshi L; Boero S; Tuccinardi T; Stura EA; Poggi A; Zocchi MR; Rossello A
    Eur J Med Chem; 2016 Mar; 111():193-201. PubMed ID: 26871660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
    Ramos CA; Ballard B; Zhang H; Dakhova O; Gee AP; Mei Z; Bilgi M; Wu MF; Liu H; Grilley B; Bollard CM; Chang BH; Rooney CM; Brenner MK; Heslop HE; Dotti G; Savoldo B
    J Clin Invest; 2017 Sep; 127(9):3462-3471. PubMed ID: 28805662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis.
    Ou ZL; Luo Z; Wei W; Liang S; Gao TL; Lu YB
    RNA Biol; 2019 Nov; 16(11):1592-1603. PubMed ID: 31402756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway.
    Alvarez M; Simonetta F; Baker J; Pierini A; Wenokur AS; Morrison AR; Murphy WJ; Negrin RS
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31211693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomas.
    Gisselbrecht C; Borchmann P; D'Amore F; Illidge TM; Zinzani PL
    Leuk Res; 2014 Sep; 38(9):1003. PubMed ID: 25193006
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis.
    Dempsey PJ
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2228-2239. PubMed ID: 28739265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells.
    Weniger MA; Tiacci E; Schneider S; Arnolds J; Rüschenbaum S; Duppach J; Seifert M; Döring C; Hansmann ML; Küppers R
    J Clin Invest; 2018 Jul; 128(7):2996-3007. PubMed ID: 29889102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of NKG2D in CD8
    Prajapati K; Perez C; Rojas LBP; Burke B; Guevara-Patino JA
    Cell Mol Immunol; 2018 May; 15(5):470-479. PubMed ID: 29400704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy.
    Ding H; Yang X; Wei Y
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.